News

Arnold & Porter's Global Antitrust Work Shortlisted Six Times for GCR Awards

April 15, 2020

Arnold & Porter's extensive antitrust work has been shortlisted for Global Competition Review's GCR Awards, which will honor the "creative, strategic and innovative competition work" for clients involved in landmark merger control matters.

The firm's work on four high-profile matters were shortlisted for "Merger Control Matter of the Year" team awards.

Partner Debbie Feinstein, who heads the firm's Global Antitrust group, and senior associate Matt Tabas represented Bristol-Myers Squibb in its acquisition of Celgene. The matter was shortlisted in both the Americas "Merger of the Year" category and the global "Matter of the Year" category that honors innovative competition work worldwide.

The firm's antitrust work for NxStage in its sale to Fresenius Medical Care was shortlisted for "Merger Control Matter of the Year" in the Americas category. The Arnold & Porter antitrust team included Debbie Feinstein, Matt Tabas, and associates Keron Morris and Jamie Long.

Brussels-based partner Niels Ersbøll coordinated Pfizer's ex-US merger control work in their joint venture with GlaxoSmithKline. The matter was shortlisted for "Merger Control Matter of the Year" in both the Europe and Asia-Pacific, Middle East, and Africa (AMEA) categories. The matter resulted in a combined revenue of £10 billion and involved merger filing in over 20 jurisdictions.

Brussels-based Arnold & Porter partner Luc Gyselen was co-counsel representing Danaher in its acquisition of General Electric's biopharma business, GE Life Sciences, for $21.4 billion in 2019. The deal was also shortlisted for "Merger Control Matter of the Year" in the Europe category.

The GCR Awards shortlist was announced shortly after Global Competition Review released its annual "GCR 100" guide, which listed Arnold & Porter among the world's leading competition law and economics practitioners for the 13th consecutive year. The guide again ranked Arnold & Porter as a "Global Elite" firm for competition law.

Email Disclaimer